Tushar Patel, MD
Plastic and Reconstructive Surgery · Red Bank, NJNPI 1205966462
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,683 of the $2,141 with a category attached, or 78.6%. 9 manufacturers reported payments, led by AbbVie at 38.5% of the total. Reporting peaked in 2019 at $1,269 and has fallen 76.7% since, to $295 in 2025.
Across 21 payments — averaging $101.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$824
- Sientra, Inc.$359
- Axogen$347
- Davol Inc.$218
- Tactile Systems Technology Inc$112
- Acell, Inc.$105
- plus $176 from 3 others
What the payments were for
- Travel & lodging$45821%
- Food & beverage$1,68379%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $824 |
| Sientra, Inc. | 1 | $359 |
| Axogen | 4 | $347 |
| Davol Inc. | 2 | $218 |
| Tactile Systems Technology Inc | 1 | $112 |
| Acell, Inc. | 1 | $105 |
| Stryker | 1 | $100 |
| Smith+Nephew | 2 | $59 |
| Checkpoint Surgical, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,141 in reported general payments places this provider in the 60th percentile of 93 plastic and reconstructive surgery providers in New Jersey.
See all plastic and reconstructive surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 13 | $110 |
| Cephalexin | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Red Bank
- John TaylorRed Bank$18K
- Peter AndrawesRed Bank$11K
- Chrisovalantis LakhianiRed Bank$7K
- Matthew KaufmanRed Bank$7K
- Mark YazidRed Bank$5K
- Michael RoseRed Bank$4K
- Andrew ElkwoodRed Bank$2K
- Sara ColeCherry Hill$63K
- Edward LeeRahway$50K
- Eric ChangFlorham Park$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.